STAT3 and hepatocellular carcinoma: demonstrated that SIRT4 inhibition in TAMs promoted HCC initiation by shifting macrophage polarization towards the M2 type through the fatty acid oxidation (FAO)–PPARδ–Signal transducer and activator of transcription 3 (STAT3) pathway (22).